Categories
Health

Moody’s Analytics on Covid outbreaks in Asia, Fed fee hikes in 2023

Asian countries need to tame the current waves of the coronavirus outbreak to prepare their economies for future rate hikes by the US Federal Reserve, an economist said Monday.

Fed officials said last week that rate hikes could happen as early as 2023, diverging from earlier comments in March that said the US Federal Reserve doesn’t expect a hike until at least 2024.

Higher US rates would attract overseas investors, and central banks in other countries may have to raise their own rates in defense. Raising interest rates could help countries prevent too much capital from leaving their economies, but increasing interest rates too quickly increases the risk of an economic slowdown.

“The Asian countries need to get Covid under control so that once the Federal Reserve starts raising interest rates, the economies here have an advantage and can make the transition,” said Steve Cochrane, chief economist for Asia-Pacific at Moody’s Analytics CNBC’s “Squawk Box Asia”.

Cochrane predicted that the US Federal Reserve could hike rates by 25 basis points once per quarter starting in 2023. The so-called dot plot of the expectations of individual Fed members indicated two rate hikes this year.

Asian countries need to get a grip on Covid so that as soon as the Federal Reserve raises interest rates, the economies have an advantage here and can also handle the transition.

Steve Cochrane

Chief Economist APAC, Moody’s Analytics

Many economies in Asia, including Japan, Taiwan and Malaysia, have seen a renewed spike in Covid cases in recent months – which has forced authorities to impose stricter social distancing measures. The new waves of infection come as vaccination progress in the region lags behind that in the US and Europe.

The World Bank said in a report this month that economic output in two-thirds of East Asian and Pacific countries will remain below pre-pandemic levels through 2022. Factors dampening potential economic growth in these countries include widespread Covid outbreaks and a collapse in global tourism, the bank said.

Cochrane noted that Covid outbreaks across the region are “stilling” domestic demand and keeping inflation moderate.

The economist said several Asian countries, including China, South Korea and Singapore, are stepping up Covid vaccinations. “It looks good, but it has to go on,” he said.

But other countries, including Thailand, Indonesia and the Philippines, have not effectively controlled the outbreak and do not yet have strong immunization programs, Cochrane added.

– CNBC’s Jeff Cox contributed to this report.

Categories
Business

AstraZeneca vaccine halt might gradual Asia’s financial restoration: Moody’s Analytics

SINGAPORE – Asia’s economic recovery could slow as more countries stop using the Covid-19 vaccine developed by AstraZeneca and Oxford University, Moody’s Analytics chief Asia-Pacific economist warned.

“It slightly increases the risk Asia is playing in terms of global economic turnaround,” Steve Cochrane told CNBC’s “Squawk Box Asia” on Tuesday.

Reports of blood clots in some people who received the AstraZeneca Oxford shot resulted in several countries – many of them in Europe – temporarily stopping using the vaccine. The World Health Organization said there was no link between the shot and an increased risk of developing blood clots and is investigating this.

Impact of vaccines on world trade

Cochrane said issues related to the AstraZeneca-Oxford vaccine could affect world trade – and that’s bad news for Asia, where many economies are dependent on trading activities.

The vaccine is of course a risk. One of the critical risks is that vaccines will have to be introduced later this year to get the world economy back on its feet.

Steve Cochrane

Asia Pacific Chief Economist, Moody’s Analytics

“There is a possibility that world trade will be adversely affected if the introduction of vaccines in Europe is delayed. This would result in a more stalled economy in Europe. This could slow the pace of world trade.” ,” he explained.

Asian countries have contained the virus with relative success, and this has helped their economies recover faster than those in Europe and the US

Fortunately, re-locks in some parts of Europe haven’t affected manufacturing, Cochrane said. He added that “almost all” of the effects of these lockdowns have affected the service sector.

“So right now it’s not that big of a problem, and world trade still seems very, very strong,” said the economist. “The vaccine is, of course, a risk. It is one of the critical risks. We have yet to see how vaccines are introduced later this year to get the world economy back on its feet.”

Thailand briefly stops the AstraZeneca vaccine

Thailand temporarily stopped using the AstraZeneca-Oxford vaccine on Friday, but authorities said Monday they would continue to administer the shots.

Thai Prime Minister Prayuth Chan-ocha was the first in the country to receive the AstraZeneca-Oxford shot on Tuesday, Reuters reported.

Elsewhere in Asia, Indonesia on Monday said it would delay the rollout of the AstraZeneca-Oxford vaccine while awaiting review by the WHO, the news agency reported.

– CNBC’s Sam Meredith contributed to this report.